Flatiron Health to Present Groundbreaking Research
Flatiron Health, a leading health technology company, has announced plans to showcase its latest research at the prestigious San Antonio Breast Cancer Symposium (SABCS). This event is known for highlighting significant advancements in the field of oncology, making it an ideal platform for Flatiron Health's contributions. The company will feature four accepted abstracts for poster presentations along with a dedicated session titled, “How Holistic Real-World Evidence Generation Advances Breast Cancer Research.”
Commitment to Oncology Research
Stephanie Reisinger, Senior Vice President and General Manager of Real-World Evidence at Flatiron Health, expressed enthusiasm about their participation at the conference. "We are deeply committed to advancing global oncology evidence generation, and we are honored to present groundbreaking research that showcases our work at this year's SABCS," she stated. Over the past decade, Flatiron Health has pioneered innovative solutions to unlock critical insights within the oncology product lifecycle, combining real-world data with cutting-edge science and technology.
Key Highlights From the Symposium
Attendees can look forward to a variety of insightful presentations at SABCS 2024. The agenda includes a poster presentation that focuses on using real-world data to enhance understanding of treatment and testing patterns among patients with early breast cancer. This research seeks to address notable gaps in genetic testing and the application of olaparib for eligible early breast cancer patients.
Comprehensive Survival Analysis
Another significant presentation features results from a large-scale real-world comparative analysis on overall survival for patients undergoing first-line therapy with CDK4/6 inhibitors alongside aromatase inhibitors. This study aims to furnish vital insights into treatment effectiveness in hormone receptor-positive, HER2-negative metastatic breast cancer.
Holistic Approaches in Breast Cancer Research
Moreover, Flatiron Health will conduct a speaking session that invites life science organizations to adopt a comprehensive approach to breast cancer research. The session will highlight three customer case studies showcasing successful strategies and innovative methodologies.
Networking Opportunities
Flatiron Health also encourages attendees to schedule meetings for further discussion on their research endeavors and insights. Participants can connect with the team to explore their abstracts and details of the networking events planned during SABCS 2024.
About the Symposium
The San Antonio Breast Cancer Symposium is renowned for being at the forefront of breast cancer research and treatment advancements. This event gathers experts from around the globe to share findings and foster collaboration within the oncology community, marking it as a crucial occasion for all involved in breast cancer research.
Flatiron Health's Innovations
Flatiron Health is dedicated to revolutionizing cancer care through the integration of real-world evidence, artificial intelligence, and advanced clinical research methodologies. By utilizing a data-driven approach, they are creating a more connected oncology ecosystem that delivers smarter care for patients facing cancer. As an independent affiliate of the Roche Group, Flatiron continues to lead the way in enhancing patient care and research outcomes.
Frequently Asked Questions
What is the focus of Flatiron Health's research at SABCS 2024?
Flatiron Health will present research focused on real-world evidence generation and its implications for breast cancer treatment and patient care.
How many presentations will Flatiron Health feature at the symposium?
Flatiron Health will be presenting four accepted abstracts for poster presentations along with a sponsored speaking session.
What topics will be covered in their presentations?
The presentations will cover treatment patterns, survival analysis, and a holistic approach to breast cancer research.
Who is the key speaker for Flatiron Health at SABCS?
Catherine Keane, RN, NP, who serves as the Senior Clinical Director at Flatiron Health, will be addressing attendees at the event.
How does Flatiron Health use data in oncology?
Flatiron Health leverages real-world data, artificial intelligence, and machine learning to drive improvements in cancer treatment and enhance the understanding of patient needs.
